References
[1] Agarwal P, Devi LS. Otomycosis in a rural community attending a tertiary care hospital: Assessment of risk factors and identification of fungal and bacterial agents. J Clin Diagn Res 2017; 11:Dc14.
[2] Saniasiaya J, Salim R, Mohamad I, Harun A. Antifungal effect of Malaysian aloe vera leaf extract on selected fungal species of pathogenic otomycosis species in in vitro culture medium. Oman Med J 2017; 32:41.
[3] Tripathi RD, Srivastava HS, Dixit SN. A fungitoxic principle from the leaves of Lawsonia inermis Lam. Experientia 1978; 34:51-2.
[4] Yaroko AA, Salim R, Mohamed Z, Mohamad I. Antifungal activity of Malaysian Henna leaves extracts on pathogenic fungi of otomycosis. Int Med J 2015; 22:389-91.
[5] Khattak SG, Gilani SN, Ikram M. Antipyretic studies on some indigenous Pakistani medicinal plants. J Ethnopharmacol 1985; 14:45-51.
[6] Lal JB, Dutta SB. Constitution of the colouring matter of Lawsonia alba or Indian Mehndi. J Indian Chem Soc 1933; 10:577-9.
[7] Bhatnagar SS, Santapau H, Desa JD, Maniar AC, Ghadially NC, Solomon MJ et al. Biological activity of Indian medicinal plants. Part I. Antibacterial, antitubercular and antifungal action. Indian J Med Res 1961; 49:799-813.
[8] Singh VK, Pandey DK. Fungitoxic studies on bark extract of Lawsonia inermis against ringworm fungi. Hindustan Antibiot Bull 1989; 31:32-5.
[9] Rahmoun N, Boucherit-Otmani Z, Boucherit K, Benabdallah M, Choukchou-Braham N. Antifungal activity of the Algerian Lawsonia inermis (Henna). Pharm Biol 2013; 51:131-5.
[10] Salim R, Daud Mk, Narayanan Ms, Ab Rani A. Assessment of vestibulotoxicity of Neem leaf (Azadirachta indica) in a rat animal model. Indian J Otol 2020; 26:159.
[11] Al Deeb S, Al Moutaery K, Khan HA, Tariq M. Exacerbation of iminodipropionitrileinduced behavioral toxicity, oxidative stress, and vestibular hair cell degeneration by gentamicin in rats. Neurotoxicol Teratol 2000; 22:213-20.
[12] Jadhav VJ, Pal M, Mishra GS. Etiological significance of Candida albicans in otitis externa. Mycopathologia 2003; 156:313-15.
[13] Ho T, Vrabec JT, Yoo D, Coker NJ. Otomycosis: clinical features and treatment implications. Otolaryngol Head Neck Surg 2006; 135:787-91.
[14] Vennewald I, Klemm E. Otomycosis: diagnosis and treatment. Clin Dermatol 2010; 28:202-11.
[15] Kanafani ZA, Perfect JR. Resistance to antifungal agents: mechanisms and clinical impact. Clin Infect Dis 2008; 46:120-8.
[16] Nemati S, Hassanzadeh R, Jahromi SK, Abadi AD. Otomycosis in the north of Iran: common pathogens and resistance to antifungal agents. Eur Arch Otorhinolaryngol 2014; 271:953-7.
[17] Rates SM. Plants as source of drugs. Toxicon 2001; 39:603-13.
[18] Hawkins JE, Keidel WD, Neff WD. Handbook of sensory physiology. Drug ototoxicity 1976; 5:707.
[19] Almola Z. The inhibitory effect of Henna Lawsonia inermis leaves on some fungi. Iraq Acad Sci J 2010; 10:501-10.
[20] Fetoni AR, Quaranta N, Marchese R, Cadoni G, Paludetti G, Sergi B. The protective role of tiopronin in cisplatin ototoxicity in Wistar rats. Int J Audiol 2004; 43:465-70.
[21] Rybak LP, Somani S. Ototoxicity. Amelioration by protective agents. Ann N Y Acad Sci 1999; 884:143-51.
[22] Albuquerque AA, Rossato M, Oliveira JA, Hyppolito MA. Understanding the anatomy of ears from guinea pigs and rats and its use in basic otologic research. Braz J Otorhinolaryngol 2009; 75:43-49.
[23] Dutta S, Sengupta P. Men and mice: relating their ages. Life sci 2016; 152:244-8.